NeuroMetrix Inc
NASDAQ:NURO
Balance Sheet
Balance Sheet Decomposition
NeuroMetrix Inc
Current Assets | 20.9m |
Cash & Short-Term Investments | 18m |
Receivables | 518.8k |
Other Current Assets | 2.3m |
Non-Current Assets | 570k |
PP&E | 543.6k |
Other Non-Current Assets | 26.4k |
Current Liabilities | 1.2m |
Accounts Payable | 215.5k |
Accrued Liabilities | 1m |
Non-Current Liabilities | 92.5k |
Other Non-Current Liabilities | 92.5k |
Balance Sheet
NeuroMetrix Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
9
|
12
|
4
|
4
|
7
|
3
|
5
|
23
|
4
|
2
|
|
Cash Equivalents |
9
|
12
|
4
|
4
|
7
|
3
|
5
|
23
|
4
|
2
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
16
|
|
Total Receivables |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
Accounts Receivables |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
1
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
2
|
2
|
|
Other Current Assets |
1
|
1
|
2
|
3
|
1
|
1
|
0
|
1
|
1
|
1
|
|
Total Current Assets |
11
|
15
|
8
|
9
|
12
|
5
|
7
|
24
|
24
|
21
|
|
PP&E Net |
0
|
1
|
1
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
|
PP&E Gross |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Accumulated Depreciation |
3
|
0
|
3
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
11
N/A
|
16
+41%
|
8
-49%
|
10
+16%
|
14
+46%
|
7
-51%
|
8
+16%
|
25
+212%
|
25
-1%
|
21
-13%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
Accrued Liabilities |
2
|
2
|
2
|
3
|
3
|
3
|
2
|
1
|
1
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
3
|
3
|
3
|
5
|
7
|
3
|
2
|
1
|
1
|
1
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
5
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
8
N/A
|
4
-56%
|
3
-6%
|
5
+38%
|
8
+72%
|
4
-45%
|
3
-37%
|
2
-39%
|
1
-22%
|
1
+2%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
154
|
164
|
178
|
191
|
191
|
195
|
197
|
199
|
204
|
210
|
|
Additional Paid In Capital |
158
|
176
|
183
|
196
|
197
|
197
|
202
|
222
|
227
|
230
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
3
N/A
|
13
+271%
|
5
-61%
|
5
+1%
|
6
+22%
|
3
-59%
|
5
+108%
|
23
+342%
|
23
+1%
|
20
-14%
|
|
Total Liabilities & Equity |
11
N/A
|
16
+41%
|
8
-49%
|
10
+16%
|
14
+46%
|
7
-51%
|
8
+16%
|
25
+212%
|
25
-1%
|
21
-13%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
1
|
4
|
7
|
8
|
2
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|